![](/img/cover-not-exists.png)
2106 POSTER Randomized clinical comparison of weekly or every-3-week 130-nanometer albumin-bound paclitaxel vs. every-3-week docetaxel as first-line therapy in patients with metastatic breast cancer
W.J. Gradishar, D. Krasnojon, S. Cheporov, A. Makhson, M. Georgy, A. Clawson, M.J. HawkinsVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70868-6
File:
PDF, 60 KB
english, 2007